Research / A / Fundamental state Inspectable configuration
State dimensions Filing 0001090872-18-000004 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
147.81% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.95% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
17.75% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
13.50% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
50.21% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
55.57% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
19.74% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
7.68% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
2.56% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 40 states Self-history eligible
Oct 31, 2021 8/8 normalized Level 3 Jan 31, 2022 9/9 normalized Level 3 Apr 30, 2022 9/9 normalized Level 3 Jul 31, 2022 9/9 normalized Level 3 Oct 31, 2022 9/9 normalized Level 3 Jan 31, 2023 9/9 normalized Level 3 Apr 30, 2023 9/9 normalized Level 3 Jul 31, 2023 9/9 normalized Level 3 Oct 31, 2023 9/9 normalized Level 3 Jan 31, 2024 9/9 normalized Level 3 Apr 30, 2024 9/9 normalized Level 3 Jul 31, 2024 9/9 normalized Level 3 Oct 31, 2024 9/9 normalized Level 3 Jan 31, 2025 9/9 normalized Level 3 Apr 30, 2025 9/9 normalized Level 3 Jul 31, 2025 9/9 normalized Level 3 Oct 31, 2025 9/9 normalized Level 3 Jan 31, 2026 9/9 normalized Level 3 Apr 30, 2026 9/9 normalized Level 3 Jul 31, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 3.94%
Current 4.95%
Delta 1.02% Cash Generation Decreased
Previous 19.88%
Current 17.75%
Delta -2.13% Growth Increased
Previous 6.43%
Current 13.50%
Delta 7.07% Inventory Pressure Increased
Previous 12.86%
Current 50.21%
Delta 37.35% Margin Increased
Previous 53.87%
Current 55.57%
Delta 1.71% Profitability Increased
Previous 18.81%
Current 19.74%
Delta 0.93% R And D Intensity Increased
Previous 7.58%
Current 7.68%
Delta 0.10% Sbc Intensity Increased
Previous 1.34%
Current 2.56%
Delta 1.22% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.